Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck × Olanzapine × Head & Neck × Clear all

NCT06995508 2026-02-17

Olanzapine for Managing Anorexia in Head and Neck Cancer Patients Undergoing Chemoradiation, MACRO Trial

Phase 2 Recruiting

Squamous Cell Carcinoma of Head and Neck

NCT05202275 2022-01-21

The Optimization of Antiemetic Regimen for C-RINV in LA-HNSCCs

Phase 2 Unknown

Squamous Cell Carcinoma of Head and Neck, Nausea, Radiation Injuries, Vomiting